• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Valeant Pharmaceuticals International



Valeant Pharmaceuticals International (4107485Q:US) was acquired by VRX:CN

Company Profile

Valeant Pharmaceuticals International operates as a research-based, specialty pharmaceutical company. The Company discovers, develops, manufactures, and markets a range of pharmaceutical products as well as focusing on products in the areas of infectious disease, neurology, and dermatology. Valeant Pharmaceuticals markets its products worldwide.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...
sec ||= nil